Pulmotect, Inc.
  • Home
  • About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • Overview
    • Our Science
    • Our Pipeline
    • Published Journal Articles
  • News
  • Contact Us

Coronavirus protection drug approved by FDA for testing in Houston

Posted on July 13, 2020 by Brenton Scott
Posted in News Coverage

Post navigation

Houston biotech company gets green light from FDA to test coronavirus-fighting drug
Pulmotect Awarded Up To $6M From Department of Defense to Complete Two COVID-19 Trials
Pulmotect Inc

3900 Essex Ln, Suite 575
Houston, TX 77027
Contact Us

© 2023
Pulmotect, Inc.